Production (Stage)
Repligen Corporation
RGEN
$121.18
-$1.36-1.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.44% | 0.56% | 9.69% | -0.21% | -7.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.44% | 0.56% | 9.69% | -0.21% | -7.38% |
| Cost of Revenue | 2.60% | 8.42% | -7.35% | -3.16% | -7.35% |
| Gross Profit | 18.13% | -6.79% | 33.24% | 2.73% | -7.40% |
| SG&A Expenses | 14.24% | -33.70% | 36.13% | 33.05% | 8.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.91% | -7.46% | 8.70% | 10.36% | -1.52% |
| Operating Income | 82.70% | 63.74% | 16.26% | -69.43% | -65.73% |
| Income Before Tax | 114.97% | -2,170.13% | -110.10% | -63.75% | -80.09% |
| Income Tax Expenses | 429.57% | -125.87% | 91.07% | -35.26% | -87.60% |
| Earnings from Continuing Operations | 76.88% | -105.89% | -103.86% | -71.13% | -78.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.88% | -105.89% | -103.86% | -71.13% | -78.51% |
| EBIT | 82.70% | 63.74% | 16.26% | -69.43% | -65.73% |
| EBITDA | 27.61% | 36.26% | 22.14% | -37.01% | -27.57% |
| EPS Basic | 75.80% | -105.02% | -103.86% | -71.23% | -78.58% |
| Normalized Basic EPS | 110.12% | 21.58% | 60.16% | -62.67% | -74.25% |
| EPS Diluted | 69.20% | -106.89% | -103.90% | -71.43% | -78.11% |
| Normalized Diluted EPS | 111.13% | 21.58% | 62.81% | -62.28% | -73.89% |
| Average Basic Shares Outstanding | 0.60% | 0.43% | 0.44% | 0.32% | 0.36% |
| Average Diluted Shares Outstanding | 0.05% | 0.43% | -1.63% | -0.75% | -0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |